XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock and Additional Paid-in Capital
Common Stock and Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests
Balance at beginning of period (in shares) at Dec. 31, 2020   170.2          
Balance at beginning of period at Dec. 31, 2020   $ 761   $ (2,446) $ 1,127   $ 17
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings         244   1
Other comprehensive income (loss)       36      
Issuance of common stock and stock options exercised (in shares)   1.4          
Issuance of common stock and stock options exercised   $ 44          
Share repurchase program (in shares)   (1.0)          
Share repurchase program         (170)    
Share-based compensation expenses   $ 29          
Dividends declared         (121)    
Balance at ending of period (in shares) at Apr. 03, 2021   170.6          
Balance at end of period at Apr. 03, 2021   $ 834   (2,410) 1,080   18
Balance at beginning of period (in shares) at Dec. 31, 2020   170.2          
Balance at beginning of period at Dec. 31, 2020   $ 761   (2,446) 1,127   17
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings $ 848            
Other comprehensive income (loss) $ 30            
Balance at ending of period (in shares) at Oct. 02, 2021   170.0          
Balance at end of period at Oct. 02, 2021   $ 952   (2,416) 1,201   15
Balance at beginning of period (in shares) at Dec. 31, 2020   170.2          
Balance at beginning of period at Dec. 31, 2020   $ 761   (2,446) 1,127   17
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06            
Balance at ending of period (in shares) at Dec. 31, 2021   169.6          
Balance at end of period at Dec. 31, 2021 $ (23) $ 989 $ (10) (2,379) 1,350 $ 10 17
Balance at beginning of period (in shares) at Apr. 03, 2021   170.6          
Balance at beginning of period at Apr. 03, 2021   $ 834   (2,410) 1,080   18
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings         293   1
Other comprehensive income (loss)       22      
Issuance of common stock and stock options exercised (in shares)   0.2          
Issuance of common stock and stock options exercised   $ 14          
Share repurchase program (in shares)   (0.5)          
Share repurchase program         (102)    
Share-based compensation expenses   $ 31          
Dividends declared         (120)    
Dividends paid to non-controlling interest on subsidiary common stock             (5)
Balance at ending of period (in shares) at Jul. 03, 2021   170.3          
Balance at end of period at Jul. 03, 2021   $ 879   (2,388) 1,151   14
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 308       307   1
Other comprehensive income (loss) (28)     (28)      
Issuance of common stock and stock options exercised (in shares)   0.3          
Issuance of common stock and stock options exercised   $ 39          
Share repurchase program (in shares)   (0.6)          
Share repurchase program         (137)    
Share-based compensation expenses   $ 34          
Dividends declared         (120)    
Balance at ending of period (in shares) at Oct. 02, 2021   170.0          
Balance at end of period at Oct. 02, 2021   $ 952   (2,416) 1,201   15
Balance at beginning of period (in shares) at Dec. 31, 2021   169.6          
Balance at beginning of period at Dec. 31, 2021 (23) $ 989 (10) (2,379) 1,350 10 17
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings         267   1
Other comprehensive income (loss)       (5)      
Issuance of common stock and stock options exercised (in shares)   1.2          
Issuance of common stock and stock options exercised   $ 50          
Share repurchase program (in shares)   (2.2)          
Share repurchase program         (493)    
Share-based compensation expenses   $ 37          
Dividends declared         (132)    
Balance at ending of period (in shares) at Apr. 02, 2022   168.6          
Balance at end of period at Apr. 02, 2022   $ 1,066   (2,384) 1,002   18
Balance at beginning of period (in shares) at Dec. 31, 2021   169.6          
Balance at beginning of period at Dec. 31, 2021 (23) $ 989 $ (10) (2,379) 1,350 $ 10 17
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 777            
Other comprehensive income (loss) $ (259)            
Share repurchase program (in shares) (3.3)            
Share repurchase program $ (749)            
Balance at ending of period (in shares) at Oct. 01, 2022   168.6          
Balance at end of period at Oct. 01, 2022 (394) $ 1,241   (2,638) 989   14
Balance at beginning of period (in shares) at Apr. 02, 2022   168.6          
Balance at beginning of period at Apr. 02, 2022   $ 1,066   (2,384) 1,002   18
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings         228   1
Other comprehensive income (loss)       (107)      
Issuance of common stock and stock options exercised   $ 2          
Share repurchase program (in shares)   (0.7)          
Share repurchase program         (162)    
Share-based compensation expenses   $ 44          
Dividends declared         (132)    
Dividends paid to non-controlling interest on subsidiary common stock             (6)
Balance at ending of period (in shares) at Jul. 02, 2022   167.9          
Balance at end of period at Jul. 02, 2022   $ 1,112   (2,491) 936   13
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 280       279   1
Other comprehensive income (loss) $ (147)     (147)      
Issuance of common stock and stock options exercised (in shares)   1.1          
Issuance of common stock and stock options exercised   $ 84          
Share repurchase program (in shares) (0.4) (0.4)          
Share repurchase program $ (94)       (94)    
Share-based compensation expenses   $ 45          
Dividends declared         (132)    
Balance at ending of period (in shares) at Oct. 01, 2022   168.6          
Balance at end of period at Oct. 01, 2022 $ (394) $ 1,241   $ (2,638) $ 989   $ 14